27 Patents
- US126068672026Highly Sensitive in Vitro Assays to Define Substrate Preferences and Sites of Nucleic-acid Binding, Modifying, and Cleaving Agents
The General Hospital Corporation
0 cites - US126010092026Highly Sensitive in Vitro Assays to Define Substrate Preferences and Sites of Nucleic-acid Binding, Modifying, and Cleaving Agents
The General Hospital Corporation
0 cites - US125902992026Variants of CRISPR from Prevotella and Francisella 1 (cpf1)
The General Hospital Corporation
0 cites - US124045252025Engineered Human-endogenous Virus-like Particles and Methods of Use Thereof for Delivery to Cells
President And Fellows Of Harvard College
0 cites - US123518142025Engineered Human-endogenous Virus-like Particles and Methods of Use Thereof for Delivery to Cells
President And Fellows Of Harvard College
0 cites - US123518152025Engineered Human-endogenous Virus-like Particles and Methods of Use Thereof for Delivery to Cells
President And Fellows Of Harvard College
0 cites - US123199382025Enhanced Virus-like Particles and Methods of Use Thereof for Delivery to Cells
President And Fellows Of Harvard College
0 cites - US122866412025Methods for Increasing Efficiency of Nuclease-induced Homology-directed Repair
The General Hospital Corporation
0 cites - US122410962025Engineered Crispr-cas9 Nucleases with Altered PAM Specificity
The General Hospital Corporation
0 cites - US122028612025Inducible, Tunable, and Multiplex Human Gene Regulation Using Crispr-cpf1
The General Hospital Corporation
0 cites - US121805202024Engineered Crispr-cas9 Nucleases with Altered PAM Specificity
The General Hospital Corporation
0 cites - US121733392024Variants of Cpf1 (cas12a) with Altered PAM Specificity
The General Hospital Corporation
0 cites - 0 cites
- US121338842024Methods of Substituting Pathogenic Amino Acids Using Programmable Base Editor Systems
Beam Therapeutics Inc.
0 cites - US121042072024Genomewide Unbiased Identification of Dsbs Evaluated by Sequencing (guide-seq)
The General Hospital Corporation
0 cites - US120656682024Rna-guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci
The General Hospital Corporation
0 cites - US119763242024Highly Sensitive in Vitro Assays to Define Substrate Preferences and Sites of Nucleic-acid Binding, Modifying, and Cleaving Agents
The General Hospital Corporation
0 cites - US119460402024Adenine DNA Base Editor Variants with Reduced Off-target RNA Editing
The General Hospital Corporation
0 cites - 0 cites
- US118982032024Highly Sensitive in Vitro Assays to Define Substrate Preferences and Sites of Nucleic-acid Binding, Modifying, and Cleaving Agents
The General Hospital Corporation
0 cites - US118592202024Engineered Crispr-cas9 Nucleases with Altered PAM Specificity
The General Hospital Corporation
0 cites - US118459872023Highly Sensitive in Vitro Assays to Define Substrate Preferences and Sites of Nucleic Acid Cleaving Agents
The General Hospital Corporation
0 cites - US117252282023Methods for Detecting Site-specific and Spurious Genomic Deamination Induced by Base Editing Technologies
The General Hospital Corporation
0 cites - US116676772023Inducible, Tunable, and Multiplex Human Gene Regulation Using Crispr-cpf1
The General Hospital Corporation
0 cites - US116347312023Using Truncated Guide Rnas (tru-grnas) to Increase Specificity for Rna-guided Genome Editing
The General Hospital Corporation
0 cites - US116240582023Engineered Crispr-cas9 Nucleases with Altered PAM Specificity
The General Hospital Corporation
0 cites - US115915892023Variants of Cpf1 (cas12a) with Altered PAM Specificity
The General Hospital Corporation
0 cites